Literature DB >> 9016526

Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene.

G Collod-Béroud1, C Béroud, L Adès, C Black, M Boxer, D J Brock, M Godfrey, C Hayward, L Karttunen, D Milewicz, L Peltonen, R I Richards, M Wang, C Junien, C Boileau.   

Abstract

Fibrillin is the major component of extracellular microfibrils. Mutations in the fibrillin gene on chromosome 15 (FBN1) were described at first in the heritable connective tissue disorder, Marfan syndrome (MFS). More recently, FBN1 has also been shown to harbor mutations related to a spectrum of conditions phenotypically related to MFS. These mutations are private, essentially missense, generally non-recurrent and widely distributed throughout the gene. To date no clear genotype/phenotype relationship has been observed excepted for the localization of neonatal mutations in a cluster between exons 24 and 32. The second version of the computerized Marfan database contains 89 entries. The software has been modified to accomodate new functions and routines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016526      PMCID: PMC146361          DOI: 10.1093/nar/25.1.147

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

1.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

2.  Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene.

Authors:  E A Putnam; M Cho; A B Zinn; J A Towbin; P H Byers; D M Milewicz
Journal:  Am J Med Genet       Date:  1996-03-29

3.  A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module.

Authors:  D R Hewett; J R Lynch; R Smith; B C Sykes
Journal:  Hum Mol Genet       Date:  1993-04       Impact factor: 6.150

Review 4.  Biochemical genetics: examples of life after cloning.

Authors:  R R McInnes; P H Byers
Journal:  Curr Opin Genet Dev       Date:  1993-06       Impact factor: 5.578

5.  Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome.

Authors:  L Pereira; M D'Alessio; F Ramirez; J R Lynch; B Sykes; T Pangilinan; J Bonadio
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

6.  Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome.

Authors:  M Godfrey; N Vandemark; M Wang; M Velinov; D Wargowski; P Tsipouras; J Han; J Becker; W Robertson; S Droste
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

7.  Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides.

Authors:  K Kainulainen; L Y Sakai; A Child; F M Pope; L Puhakka; L Ryhänen; A Palotie; I Kaitila; L Peltonen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

8.  Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome.

Authors:  L C Adès; E A Haan; A F Colley; R I Richard
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

9.  The skipping of constitutive exons in vivo induced by nonsense mutations.

Authors:  H C Dietz; D Valle; C A Francomano; R J Kendzior; R E Pyeritz; G R Cutting
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

10.  Software and database for the analysis of mutations in the human FBN1 gene.

Authors:  G Collod; C Béroud; T Soussi; C Junien; C Boileau
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

View more
  9 in total

1.  Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing.

Authors:  J Körkkö; S Annunen; T Pihlajamaa; D J Prockop; L Ala-Kokko
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 2.  Marfan syndrome in the third Millennium.

Authors:  Gwenaëlle Collod-Béroud; Catherine Boileau
Journal:  Eur J Hum Genet       Date:  2002-11       Impact factor: 4.246

Review 3.  The molecular genetics of Marfan syndrome and related disorders.

Authors:  P N Robinson; E Arteaga-Solis; C Baldock; G Collod-Béroud; P Booms; A De Paepe; H C Dietz; G Guo; P A Handford; D P Judge; C M Kielty; B Loeys; D M Milewicz; A Ney; F Ramirez; D P Reinhardt; K Tiedemann; P Whiteman; M Godfrey
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

4.  Software and database for the analysis of mutations in the human WT1 gene.

Authors:  C Jeanpierre; C Béroud; P Niaudet; C Junien
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

5.  Marfan Database (third edition): new mutations and new routines for the software.

Authors:  G Collod-Béroud; C Béroud; L Ades; C Black; M Boxer; D J Brock; K J Holman; A de Paepe; U Francke; U Grau; C Hayward; H G Klein; W Liu; L Nuytinck; L Peltonen; A B Alvarez Perez; T Rantamäki; C Junien; C Boileau
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

6.  Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils.

Authors:  X Yuan; A K Downing; V Knott; P A Handford
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

7.  Family-based whole-exome sequencing identifies novel loss-of-function mutations of FBN1 for Marfan syndrome.

Authors:  Zhening Pu; Haoliang Sun; Junjie Du; Yue Cheng; Keshuai He; Buqing Ni; Weidong Gu; Juncheng Dai; Yongfeng Shao
Journal:  PeerJ       Date:  2018-11-13       Impact factor: 2.984

8.  Marfan Syndrome Variability: Investigation of the Roles of Sarcolipin and Calcium as Potential Transregulator of FBN1 Expression.

Authors:  Louise Benarroch; Mélodie Aubart; Marie-Sylvie Gross; Marie-Paule Jacob; Pauline Arnaud; Nadine Hanna; Guillaume Jondeau; Catherine Boileau
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

9.  Reference Expression Profile of Three FBN1 Transcript Isoforms and Their Association with Clinical Variability in Marfan Syndrome.

Authors:  Louise Benarroch; Mélodie Aubart; Marie-Sylvie Gross; Pauline Arnaud; Nadine Hanna; Guillaume Jondeau; Catherine Boileau
Journal:  Genes (Basel)       Date:  2019-02-11       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.